Deliberate AI

Deliberate AI is a company that specializes in ambient multimodal AI for mental health. The company uses behavioral signal processing to understand signs of mental and neurological health. Its product offerings include CNS clinical trials and biomarker research tools, as well as a digital health assistant named Sophia™. Deliberate AI provides AI-generated clinical notes to reduce staff burnout and has developed a telemedicine API for mental health triage. The company integrates data from words, vocal and visual cues, and other modalities using multimodal AI. One of its key platforms, Multitude™, is designed for CNS biomarker discovery and development, extracting hundreds of behavioral and physiological features from video recordings and facilitating the fusion of different biomarker modalities. Deliberate AI has published over 600 papers, generating 64,000 citations, and has received tens of millions in funding from major grant-making agencies. The company pioneered the field with a 2009 landmark multimodal depression study and uses AI-COAs™ to enhance endpoint reliability and reduce trial sizes by 10-20%. Additionally, Deliberate AI offers real-time comprehensive rater-monitoring through AI-EVAL™ and automates readiness assessments of staff in high-risk environments. The company tracks patients over time to identify individual symptom trajectories and prodromal signals and offers a platform for creating Multimodal Biomarker Constellations™. Deliberate AI also uses ambient symptom tracking to avoid missing data and self-report bias, providing automated remote collection and charting of patient measures.